News and publications
Invoke Bio Wins $100,000 QB3 Mentoring Program Award
Invoke Bio was awarded $100,000 through the QB3 Mentoring Program's Proof-of-Concept Award, supporting research and development for early-stage biotech companies. Co-Founder and CEO TJ Sears noted the funding will help catalyze the company's mission to deliver personalized immunotherapies for patients fighting cancer.
More news

Open Data
Designing a Personalized Cancer Vaccine from Sid Sijbrandij's Data
Designing a Personalized Cancer Vaccine from Sid Sijbrandij's Data

QB3
Teaching Cancer Vaccines What to Target: Invoke Bio Turns to AI
Teaching Cancer Vaccines What to Target: Invoke Bio Turns to AI

bioRxiv Preprint
Learning What Cancer Reveals: Introducing NEMo
Learning What Cancer Reveals: Introducing NEMo

QB3
Invoke Bio Wins $100,000 QB3 Mentoring Program Award
Invoke Bio Wins $100,000 QB3 Mentoring Program Award
See all
news